-
Je něco špatně v tomto záznamu ?
Liver-Specific, but Not Retina-Specific, Hepcidin Knockout Causes Retinal Iron Accumulation and Degeneration
BH. Baumann, W. Shu, Y. Song, J. Sterling, Z. Kozmik, S. Lakhal-Littleton, JL. Dunaief,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
FS/12/63/29895
British Heart Foundation - United Kingdom
R01 EY015240
NEI NIH HHS - United States
T32 AI070077
NIAID NIH HHS - United States
T32 GM007170
NIGMS NIH HHS - United States
NLK
Free Medical Journals
od 1925 do Před 1 rokem
Open Access Digital Library
od 1998-07-01
Elsevier Open Access Journals
od 2014-09-01 do Před 1 rokem
Elsevier Open Archive Journals
od 1998-07-01 do Před 1 rokem
- MeSH
- degenerace retiny etiologie metabolismus patologie MeSH
- hematoretinální bariéra MeSH
- hepcidiny fyziologie MeSH
- játra metabolismus patologie MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- přetížení železem etiologie metabolismus patologie MeSH
- retina metabolismus patologie MeSH
- železo metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
The liver secretes hepcidin (Hepc) into the bloodstream to reduce blood iron levels. Hepc accomplishes this by triggering degradation of the only known cellular iron exporter ferroportin in the gut, macrophages, and liver. We previously demonstrated that systemic Hepc knockout (HepcKO) mice, which have high serum iron, develop retinal iron overload and degeneration. However, it was unclear whether this is caused by high blood iron levels or, alternatively, retinal iron influx that would normally be regulated by retina-produced Hepc. To address this question, retinas of liver-specific and retina-specific HepcKO mice were studied. Liver-specific HepcKO mice had elevated blood and retinal pigment epithelium (RPE) iron levels and increased free (labile) iron levels in the retina, despite an intact blood-retinal barrier. This led to RPE hypertrophy associated with lipofuscin-laden lysosome accumulation. Photoreceptors also degenerated focally. In contrast, there was no change in retinal or RPE iron levels or degeneration in the retina-specific HepcKO mice. These data indicate that high blood iron levels can lead to retinal iron accumulation and degeneration. High blood iron levels can occur in patients with hereditary hemochromatosis or result from use of iron supplements or multiple blood transfusions. Our results suggest that high blood iron levels may cause or exacerbate retinal disease.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006172
- 003
- CZ-PrNML
- 005
- 20200525111645.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ajpath.2019.05.022 $2 doi
- 035 __
- $a (PubMed)31287995
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Baumann, Bailey H $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
- 245 10
- $a Liver-Specific, but Not Retina-Specific, Hepcidin Knockout Causes Retinal Iron Accumulation and Degeneration / $c BH. Baumann, W. Shu, Y. Song, J. Sterling, Z. Kozmik, S. Lakhal-Littleton, JL. Dunaief,
- 520 9_
- $a The liver secretes hepcidin (Hepc) into the bloodstream to reduce blood iron levels. Hepc accomplishes this by triggering degradation of the only known cellular iron exporter ferroportin in the gut, macrophages, and liver. We previously demonstrated that systemic Hepc knockout (HepcKO) mice, which have high serum iron, develop retinal iron overload and degeneration. However, it was unclear whether this is caused by high blood iron levels or, alternatively, retinal iron influx that would normally be regulated by retina-produced Hepc. To address this question, retinas of liver-specific and retina-specific HepcKO mice were studied. Liver-specific HepcKO mice had elevated blood and retinal pigment epithelium (RPE) iron levels and increased free (labile) iron levels in the retina, despite an intact blood-retinal barrier. This led to RPE hypertrophy associated with lipofuscin-laden lysosome accumulation. Photoreceptors also degenerated focally. In contrast, there was no change in retinal or RPE iron levels or degeneration in the retina-specific HepcKO mice. These data indicate that high blood iron levels can lead to retinal iron accumulation and degeneration. High blood iron levels can occur in patients with hereditary hemochromatosis or result from use of iron supplements or multiple blood transfusions. Our results suggest that high blood iron levels may cause or exacerbate retinal disease.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a hematoretinální bariéra $7 D001813
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hepcidiny $x fyziologie $7 D064451
- 650 _2
- $a železo $x metabolismus $7 D007501
- 650 _2
- $a přetížení železem $x etiologie $x metabolismus $x patologie $7 D019190
- 650 _2
- $a játra $x metabolismus $x patologie $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a retina $x metabolismus $x patologie $7 D012160
- 650 _2
- $a degenerace retiny $x etiologie $x metabolismus $x patologie $7 D012162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Shu, Wanting $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.
- 700 1_
- $a Song, Ying $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
- 700 1_
- $a Sterling, Jacob $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania.
- 700 1_
- $a Kozmik, Zbynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Academy of Sciences of the Czech Republic (ASCR), Prague, Czech Republic.
- 700 1_
- $a Lakhal-Littleton, Samira $u Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
- 700 1_
- $a Dunaief, Joshua L $u F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 305 Stellar-Chance Laboratory, Philadelphia, Pennsylvania. Electronic address: jdunaief@pennmedicine.upenn.edu.
- 773 0_
- $w MED00009121 $t The American journal of pathology $x 1525-2191 $g Roč. 189, č. 9 (2019), s. 1814-1830
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31287995 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525111646 $b ABA008
- 999 __
- $a ok $b bmc $g 1525030 $s 1096228
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 189 $c 9 $d 1814-1830 $e 20190706 $i 1525-2191 $m American journal of pathology $n Am J Pathol $x MED00009121
- GRA __
- $a FS/12/63/29895 $p British Heart Foundation $2 United Kingdom
- GRA __
- $a R01 EY015240 $p NEI NIH HHS $2 United States
- GRA __
- $a T32 AI070077 $p NIAID NIH HHS $2 United States
- GRA __
- $a T32 GM007170 $p NIGMS NIH HHS $2 United States
- LZP __
- $a Pubmed-20200511